Claude Négrier was head of the Haematology Department at Hôpital Louis Pradel in Lyon, France and Director of the Haemophilia Comprehensive Care Centre at this institution until the end of last year. He is currently Emeritus Professor of Haematology at the university of Lyon.
Professor Négrier has authored more than 160 peer-reviewed publications and acts as a reviewer for different journals including Blood, The Journal of Thrombosis and Haemostasis and Haemophilia, for which he is a member of the editorial board.
Professor Négrier’s research interests focus on molecular and cellular biology of factor VIII and factor IX, clinical evaluation of therapeutic modalities in patients who have developed an inhibitor and clinical utility of surrogate markers. In addition, he has a keen interest in the current and future approaches for treating patients with haemophilia, including innovative replacement and non-replacement molecules as well as gene therapy.
